Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Boston, MA
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Lansing, MI
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Neptune, NJ
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Neptune, NJ
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Charlotte, NC
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Duncansville, PA
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
mi
from
Berlin,
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
mi
from
Berlin,
Click here to add this to my saved trials
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Treatment of Systemic Lupus Erythematosus With CTLA4-IgG4m Plus Cyclophosphamide: A Phase I/IIA Study
Status: Enrolling
Updated:  1/10/2017
University of California at San Francisco
mi
from
San Francisco, CA
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Treatment of Systemic Lupus Erythematosus With CTLA4-IgG4m Plus Cyclophosphamide: A Phase I/IIA Study
Status: Enrolling
Updated: 1/10/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Treatment of Systemic Lupus Erythematosus With CTLA4-IgG4m Plus Cyclophosphamide: A Phase I/IIA Study
Status: Enrolling
Updated:  1/10/2017
Columbia University Medical Center
mi
from
New York, NY
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Treatment of Systemic Lupus Erythematosus With CTLA4-IgG4m Plus Cyclophosphamide: A Phase I/IIA Study
Status: Enrolling
Updated: 1/10/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
Allogeneic Stem Cell Transplantation in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  1/12/2017
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
Allogeneic Stem Cell Transplantation in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 1/12/2017
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome
A Phase I-II Open- Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Autologous Adipose Stem Cell (Adult Human) to Subjects With Refractory Rheumatoid Arthritis, Relapsing Systemic Lupus Erythematosus or Sharp's Syndrome
Status: Enrolling
Updated:  3/2/2017
Arkansas Heart Hospital
mi
from
Little Rock, AR
Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome
A Phase I-II Open- Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Autologous Adipose Stem Cell (Adult Human) to Subjects With Refractory Rheumatoid Arthritis, Relapsing Systemic Lupus Erythematosus or Sharp's Syndrome
Status: Enrolling
Updated: 3/2/2017
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease
Immune Deregulation in Patients With SLE
Status: Enrolling
Updated:  5/23/2017
Weill Medical College of Cornell University
mi
from
New York, NY
Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease
Immune Deregulation in Patients With SLE
Status: Enrolling
Updated: 5/23/2017
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
Status: Enrolling
Updated:  7/17/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
Status: Enrolling
Updated: 7/17/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Southwest Shoulder, Elbow and Hand Center
mi
from
Tucson, AZ
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Southwest Shoulder, Elbow and Hand Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Bloomington Bone and Joint Clinic
mi
from
Bloomington, IN
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Bloomington Bone and Joint Clinic
mi
from
Bloomington, IN
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Reconstructive Hand Surgeons of Indiana
mi
from
Carmel, IN
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Reconstructive Hand Surgeons of Indiana
mi
from
Carmel, IN
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Indiana Hand Center
mi
from
Indianapolis, IN
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Indiana Hand Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
The Center for Ortho/ Neuro Care & Research
mi
from
Bend, OR
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
The Center for Ortho/ Neuro Care & Research
mi
from
Bend, OR
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
ROC Houston, PA
mi
from
Houston, TX
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
ROC Houston, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Fondren Orthopedic Group, L.L.P.
mi
from
Houston, TX
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Fondren Orthopedic Group, L.L.P.
mi
from
Houston, TX
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Hand Center of San Antonio
mi
from
San Antonio, TX
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Hand Center of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Los Angeles, CA
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Palo Alto, CA
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Palo Alto, CA
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Gainesville, FL
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Miami, FL
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Miami, FL
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Farmington Hills, MI
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Brooklyn, NY
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
New York, NY
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
New York, NY
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Chapel Hill, NC
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Charlotte, NC
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Columbus, OH
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Columbus, OH
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Hershey, PA
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Hershey, PA
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Chattanooga, TN
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Dallas, TX
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Dallas, TX
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Houston, TX
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Houston, TX
Click here to add this to my saved trials
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated:  9/21/2017
AURA-LV Site
mi
from
Dhaka,
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Status: Enrolling
Updated: 9/21/2017
AURA-LV Site
mi
from
Dhaka,
Click here to add this to my saved trials
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Status: Enrolling
Updated:  9/29/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Status: Enrolling
Updated: 9/29/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Vitamin D to Improve Endothelial Function in SLE
Vitamin D Repletion to Improve Endothelial Function in Lupus Patients
Status: Enrolling
Updated:  9/29/2017
Medical University of South Carolina
mi
from
Charleston, SC
Vitamin D to Improve Endothelial Function in SLE
Vitamin D Repletion to Improve Endothelial Function in Lupus Patients
Status: Enrolling
Updated: 9/29/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
Clinical Research Facility
mi
from
Anniston, AL
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
Clinical Research Facility
mi
from
Anniston, AL
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
Clinical Research Facility
mi
from
El Cajon, CA
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
Clinical Research Facility
mi
from
El Cajon, CA
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
Clinical Research Facility
mi
from
Lakewood, CA
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
Clinical Research Facility
mi
from
Lakewood, CA
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
Clinical Research Facility
mi
from
Los Angeles, CA
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
Clinical Research Facility
mi
from
Clearwater, FL
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
Clinical Research Facility
mi
from
Debary, FL
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
Clinical Research Facility
mi
from
Debary, FL
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
Clinical Research Facility
mi
from
Orlando, FL
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
Clinical Research Facility
mi
from
Grand Blanc, MI
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
Clinical Research Facility
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
Clinical Research Facility
mi
from
Austin, TX
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  10/6/2017
mi
from
Sofia,
MSC2364447C Phase 1b in Systemic Lupus Erythematosus
A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 10/6/2017
mi
from
Sofia,
Click here to add this to my saved trials